Precision Targeting Using RNA

At WiNK, we are pioneering treatment approaches for diabetes and solid tumors through our innovative modified RNA aptamer therapeutics.

COMPANY

At WiNK, we are pioneering treatment approaches for diabetes and solid tumors through our innovative modified RNA aptamer therapeutics.

We are advancing a pipeline of modified RNA therapeutics in order to treat, and potentially cure, deadly diseases such as diabetes and cancer.

Keep up with the latest publications and news about our journey to greatly increase the well-being and lifespan of people with diabetes and cancers.